Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IW-9179 in Functional Dyspepsia
NCT01712412Phase 2Terminated
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Oct 2012
- Primary completion
- Feb 2014
- Modality
- Modified Peptides, Native Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of recanaclotide in functional dyspepsia (FD), sponsored by Ironwood Pharmaceuticals. Started Oct 2012; status: terminated.
02
Drugs
recanaclotide
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT01712412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712412.